Friday 23 May, 2025 07:25 PM
Site map | Locate Us | Login
   Kirloskar Inds gains after Q4 PAT climbs 95% QoQ to Rs 47 cr    Shilpa Medicare zooms as arm partners with Orion Corporation    AIA Engineering gains after Q4 PAT rises 10% QoQ to Rs 285 crore    Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin Tablets    Bharti Airtel Ltd Partly Paidup leads losers in 'A' group    Dhabriya Polywood soars as Q4 PAT jumps 32% YoY to Rs 5 crore    Devyani Intl Q4 net loss widens to Rs 15 cr    Premier Explosives Ltd leads losers in 'B' group    Premier Explosives drops after weak Q4 numbers    Greenpanel Inds Q4 PAT falls 1% YoY to Rs 29 crore    Volumes spurt at Honasa Consumer Ltd counter    BEML gains as Q4 PAT jumps 12% YoY to Rs 288 cr    Healthcare shares slide    Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr    Mankind Pharma Ltd slips for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Honasa Consumer sails higher on strong quarterly winds
23-May-25   11:41 Hrs IST

Gross profit climbed 14% to Rs 377 crore, lifting the gross margin slightly to 70.7% (from 70.0%), thanks to a better product mix and operational efficiency. However, EBITDA slipped 18.2% to Rs 27 crore, with the margin contracting to 5.1% from 7.0%.

Advertising remained a key lever, with ad spends rising 15% to Rs 184 crore, now forming 34.4% of revenue.

On the bottom line, Profit Before Tax (PBT) came in at Rs 32 crore, down 18% YoY, as margins narrowed to 6.0% from 8.3%. Net profit (PAT) dropped 17% YoY to Rs 25 crore, and the PAT margin shrunk to 4.7% from 6.5%.

Mamaearth's strategy shift shows green shoots with double-digit YoY growth in key categories across e-Commerce and Modern Trade in Q4 FY25, backed building leadership in focus categories, optimal media mix modelling, and awareness led brand building.

It also gained market share in core categories, now ranking among the Top 5 in face wash, and expanded its retail footprint 26% YoY to 2.36 lakh outlets.

Meanwhile, The Derma Co. crossed Rs 100 crore Annual Recurring Revenue (ARR) in offline sales, continuing to dominate on digital platforms too.

The company's direct distribution model is gaining traction, with over 1 lakh unique outlets billed in FY25. Notably, direct distributor contribution shot up from 38% in FY24 to 71% in Q4 FY25.

The company's net profit fell 34.23% to Rs 73 crore while revenue increased 8% to Rs 2,067 crore in FY25 over FY24. Gross profit rose 9% to Rs 1,454 crore in FY25. Gross profit margin inproved to 70.3% in FY25 as against 69.8% in FY25.

The company's consolidated net cash from operating activities stood at Rs 102.18 crore in FY25, lower than Rs 235.33 crore in FY24.

Honasa Consumer is India's largest digital-first beauty and personal care company, with a diverse portfolio of six brands.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41051736
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited